Evidence map›Paper›PMID 42862330›Full record

ReviewJournal of neural transmission (Vienna, Austria : 1996)2026

Diagnostic approach and treatment options for myoclonus.

Cezar Thomas Suratos, Jane Marice Pascual, Arlene Ng, Rosalia Teleg, Victor S C Fung

Abstract readReview
PubMed Publisher
In one paragraph

Review in Journal of neural transmission (Vienna, Austria : 1996), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Cezar Thomas SuratosDepartment of Neurosciences, De La Salle Medical and Health Sciences Institute, Dasmariñas, Cavite, Philippines. ctsuratos@my.dlshsi.edu.ph.
Jane Marice PascualSection of Neurology, Socomedics Medical Center, Koronadal City, South Cotabato, Philippines.
Arlene NgMovement Disorders Service and Section of Neurology, Institute for Neurosciences, St. Luke's Medical Center, Quezon City, Philippines.
Rosalia TelegDepartment of Neurosciences, Makati Medical Center, Makati City, Philippines.
Victor S C FungMovement Disorders Unit, Department of Neurology, Westmead Hospital and Sydney Medical School, University of Sydney, Sydney, NSW, Australia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Myoclonus is a hyperkinetic movement disorder characterized by sudden, brief involuntary movements that are shock-like and/or jerky. Positive myoclonus is generated by abrupt muscular contractions, which occur synchronously in the affected body part, while negative myoclonus, also referred to as asterixis, results from a brief interruption or silencing of muscle activity leading to a sudden movement due to loss of muscle tone. Myoclonus manifests across a highly heterogeneous group of neurologic and systemic disorders. Due to its varied clinical presentations and multiple etiologies, diagnosing and managing myoclonus in clinical practice remains challenging. The authors retrieved publications that focus on myoclonus as a movement disorder from various electronic databases. The included articles contained discussion on clinical or electrophysiologic findings of myoclonus and its classification. This review outlines a practical diagnostic guide for clinicians that includes consideration of the newly developed 2025 International Association of Parkinsonism and Related Disorders (IAPRD) Axis classification system. This consensus-based framework organizes the diagnostic process into clinical features (Axis 1 A), clinical neurophysiology (Axis 1B), and etiology (Axis II). By systematically evaluating historical data, physical examination findings, and ancillary tests, clinicians can successfully arrive at a clinical syndrome which helps guide investigations to determine the underlying etiology. Neurophysiological assessments are important in determining the specific neuroanatomic generator (cortical, cortical-subcortical, subcortical, brainstem, spinal, propriospinal, peripheral). Categorizing myoclonus by its physiological subtype ultimately dictates the most effective symptomatic treatments. While resource-limited settings may necessitate a primarily clinical approach, employing this step-by-step localization aids in avoiding unnecessary testing and ensures optimal patient care.

Indexed as

Axis classificationClinical neurophysiologyHyperkinetic movement disorderMyoclonus

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.